Sugi Predict

Sugi Predict / Compounds / SCHEMBL7201421

SCHEMBL7201421

SCHEMBL7201421

O=C=CCC(C(=O)O)N1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.50
▸ POLB P06746 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28108702 0.81 HSD17B10 (0.50) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
SCHEMBL465025 0.73 HSD17B10 (0.53) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
SCHEMBL997677 0.73 HSD17B10 (0.53) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
SCHEMBL1194367 0.73 HSD17B10 (0.61) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
SCHEMBL28297076 0.73 HSD17B10 (0.61) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
SCHEMBL24550941 0.73 HSD17B10 (0.53) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
SCHEMBL997678 0.73 HSD17B10 (0.53) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL10475934 0.72 HSD17B10 (0.51) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL32662666 0.72 HSD17B10 (0.51) HSD17B10POLBMAPK1L3MBTL1ALDH1A1
SCHEMBL5718257 0.72 ALDH1A1 (0.58) HSD17B10POLBMAPK1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6656910-B2 Serine protease inhibitors CORTECH, INC. 2003-12-02 — — US disclosed
US-6656911-B2 Oxadiazole ring structure peptoids which are useful as inhibitors of serine proteases CORTECH, INC. 2003-12-02 — — US disclosed
US-20030203851-A1 Substituted oxadiazole, peptoids which are useful for treating adult respiratory distress syndrome, septic shock and myocardial ischemia-reperfusion injury CORTECH, INC. 2003-10-30 — — US disclosed
US-6608175-B2 Oxadiazole, thiadiazoles or triazole metal derivatives reacted with an amine containing aldehyde, deprotecting, coupling with an acid and oxidizing to create substituted oxadiazole, thiadiazole or triazole peptoids CORTECH, INC. 2003-08-19 — — US disclosed
US-20030060418-A1 Serine protease inhibitors CORTECH, INC. 2003-03-27 — — US disclosed
US-20020119998-A1 Serine protease inhibitors CORTECH, INC. 2002-08-29 — — US disclosed
US-20020119985-A1 Serine protease inhibitors CORTECH, INC. 2002-08-29 — — US disclosed
US-6150334-A SUBSTITUTED OXADIAZOLE, THIADIAZOLE AND TRIAZOLE STRUCTURES WHICH ARE USEFUL AS INHIBITORS OF SERINE PROTEASES, INCLUDING HUMAN NEUTROPHIL ELASTASE CORTECH, INC. 2000-11-21 — — US disclosed
US-6015791-A Serine protease inhibitors-cycloheptane derivatives CORTECH INC. (US) 2000-01-18 — — US disclosed
US-6001811-A TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME, SEPSIS, MULTIPLE ORGAN FAILURE CORTECH INC. (US) 1999-12-14 — — US disclosed
US-5998379-A USEFUL AS INHIBITORS OF SERINE PROTEASES, IN PARTICULAR HUMAN NEUTROPHIL ELASTASE, TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME, SEPTIC SHOCK, AND MYOCARDIAL ISCHEMIA-REPERFUSION INJURY CORTECH INC. (US) 1999-12-07 — — US disclosed
EP-0954526-A2 SERINE PROTEASE INHIBITORS CORTECH, INC. (US) 1999-11-10 — — EP disclosed
US-5891852-A Serine protease inhibitors-cycloheptane derivatives CORTECH, INC. (US) 1999-04-06 — — US disclosed
US-5869455-A SUBSTITUTED OXADIAZOLE, THIADIAZOLE AND TRIAZOLE PEPTOIDS WHICH ARE USEFUL AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE CORTECH, INC. (US) 1999-02-09 — — US disclosed
US-5861380-A OXADIAZOLE, THIADIAZOLE AND TRIAZOLE PEPTOIDS AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIARTHRITIC,-INFLAMMATORY,-ISCHEMIC,-TUMOR AND -CARCINOGENIC AGENTS AND OTHER HNE-MEDIATED CONDITIONS CORTECH, INC. (US) 1999-01-19 — — US disclosed
US-5807829-A RESPIRATORY SYSTEM DISORDERS; SESPIC SHOCK; ORGAN FAILURE CORTECH, INC. (US) 1998-09-15 — — US disclosed
US-5801148-A Serine protease inhibitors-proline analogs CORTECH, INC. (US) 1998-09-01 — — US disclosed
WO-1998024806-A2 SUBSTITUTED OXADIAZOLE, THIADIAZOLE AND TRIAZOLE SERINE PROTEASE INHIBITORS CORTECH, INC. (US) 1998-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020119985-A1 Serine protease inhibitors PRSS1, SERPINB1, SERPINE1 HSD17B10 1600/4885POLB 4271/4885MAPK1 3107/4885
US-20030203851-A1 Substituted oxadiazole, peptoids which are useful for treating adult respiratory distress syndrome, septic shock and myocardial ischemia-reperfusion injury TNNI3, PEPD, STK35 HSD17B10 1613/4885POLB 3244/4885MAPK1 3529/4885
US-20030060418-A1 Serine protease inhibitors PRSS1, SERPINB1, SERPINE1 HSD17B10 1600/4885POLB 4271/4885MAPK1 3107/4885
US-20020119998-A1 Serine protease inhibitors PRSS1, SERPINB1, SERPINE1 HSD17B10 1600/4885POLB 4271/4885MAPK1 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.